Native Tissue Repair With Surgical Pelvic Organ Pessary - an RCT
Launched by CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST · Jun 16, 2016
Trial Information
Current as of April 25, 2025
Unknown status
Keywords
ClinConnect Summary
Prolapse of the vagina is a common problem for women and varies from mildly bothersome to very problematic. About one in ten women in the developed world will require surgery for prolapse in their lifetime. The results of surgery are not perfect and some of women will develop prolapse again or not be satisfied with the result.
In this study a soft silicone support (SPOP) is inserted into the vagina straight after prolapse surgery. Women who have agreed to the study will be randomly chosen to have the SPOP at the time of surgery. There will be 120 patients in the study; so 60 women will hav...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with symptomatic pelvic organ prolapse requiring an anterior vaginal repair at the study centre.
- • Currently on the hospital waiting list for vaginal native tissue repair
- • Willingness to participate
- • Medically fit for surgery
- • 18 years or over
- • Reasonable level of English to complete questionnaires
- • Patients have not been recommended surgery that involves colpocliesis, mesh, or laparoscopic approach
- Exclusion Criteria:
- • Asymptomatic pelvic organ prolapse
- • Refusal to participate
- • Medically unfit for surgery
- • Under 18
- • Unable to complete questionnaires due to poor level of english
- • Patients has been recommended surgery that involves colpocliesis, mesh, or laparoscopic approach
About Cambridge University Hospitals Nhs Foundation Trust
Cambridge University Hospitals NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent academic health science center, it integrates cutting-edge research with clinical practice, fostering collaboration between healthcare professionals, researchers, and patients. The Trust is committed to delivering high-quality, evidence-based healthcare while actively participating in the development of new therapies and interventions aimed at enhancing health outcomes. With a focus on excellence in clinical research, Cambridge University Hospitals aims to translate scientific discoveries into effective treatments, ultimately benefiting the wider community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cambridge, Cambridgeshire, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials